Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
British Journal of Cancer
|
January 1, 1997
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells
C Marth, M Widschwendter, J Kaern, et al.
Gynecologic Oncology
|
July 27, 1999
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases
K Mayerhofer, A Obermair, G Windbichler, et al.
International Journal of Cancer
|
September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer
A G Zeimet, C Natoli, M Herold, et al.
Anticancer Research
|
January 1, 1996
Interaction of retinoic acid and interferon-alpha in breast cancer cell lines
M Widschwendter, G Daxenbichler, F Bachmair, et al.
Gynecologic Oncology
|
May 2, 2001
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients
K Bodner, B Bodner-Adler, A Obermair, et al.
Oncology Reports
|
April 18, 2000
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer
A Obermair, E Petru, G Windbichler, et al.
International Journal of Cancer
|
September 17, 1996
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells
C Marth, A G Zeimet, M Herold, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
British Journal of Cancer
|
January 1, 1997
Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells
C Marth, M Widschwendter, J Kaern, et al.
Gynecologic Oncology
|
July 27, 1999
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases
K Mayerhofer, A Obermair, G Windbichler, et al.
International Journal of Cancer
|
September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer
A G Zeimet, C Natoli, M Herold, et al.
Anticancer Research
|
January 1, 1996
Interaction of retinoic acid and interferon-alpha in breast cancer cell lines
M Widschwendter, G Daxenbichler, F Bachmair, et al.
Gynecologic Oncology
|
May 2, 2001
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients
K Bodner, B Bodner-Adler, A Obermair, et al.
Oncology Reports
|
April 18, 2000
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer
A Obermair, E Petru, G Windbichler, et al.
International Journal of Cancer
|
September 17, 1996
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells
C Marth, A G Zeimet, M Herold, et al.
Page
of 2